Small biosensors
- large opportunities in medicine

Early warning – Early action

 

Alertis Medical AS is a medical device company with a new and unique technology for biosensors that will help save patients  health and lives by providing early warning about critical changes in blood perfusion and respiration. The miniaturized biosensors are easy to use and will save health care expenses.

 

The technology of miniaturized biosensors addresses a considerable need in modern medicine by providing early warning of life threatening conditions, by measuring tissue pCO2, real time, on-line, as an indicator of adequate tissue oxygenation. There are no reliable, cost effective and user friendly methods available for this purpose today. Alertis unique biosensor technology will enable early warning and thereby early intervention of critical conditions related to changes in blood flow and respiration, providing a new tool for reducing mortality and morbidity as well as  medical expenses.

 

This is a universal monitoring tool in modern medicine, with numerous potential applications which are about to be explored.

 

Some key clinical areas for the biosensors will primarily be post operative monitoring for the first 2-5 days following:
 

·          Orthopaedic surgery

·          Plastic surgery

·          Cardiac surgery

·          Vascular surgery

·          Solid Organ Transplantation

 

and general monitoring to detect critical conditions such as:
 

·          Sepsis   

·          Shock

·          ARDS (Acute Respiratory Distress Syndrome

 

The total market potential for the biosensor portfolio is estimated to more than € 2 billion. The sensors can be produced at low cost and will provide excellent health economy for the users.

 

Alertis’ development strategy is focused key indications with documented clinical need.  The company has obtained market clearance by the CE mark for the EU market and FDA clearance (510(k)) for USA for its first biosensor product IscAlert™.   

The company works closely with the Interventional Centre at Rikshospitalet-Radiumhospitalet (the National Hospital, where the inventors are working) where significant R&D activities are carried out.



 
Alertis Medical AS Parkveien 53B 0256 Oslo Norway Tel: +47 21 01 33 00 Fax: +47 21 01 33 01 mail@alertis.no
webdesign: Mons Rønning AS / Maki Design